Dihydropyridine Ca2+ entry blockers selectively inhibit peak I cAMP phosphodiesterase
- 31 August 1983
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 93 (1-2), 107-112
- https://doi.org/10.1016/0014-2999(83)90036-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulinBiochemical and Biophysical Research Communications, 1982
- Calcium antagonists receptor sites labeled with [3H]nitrendipineEuropean Journal of Pharmacology, 1982
- Heterogeneity of Biochemical Actions Among VasodilatorsJournal of Pharmaceutical Sciences, 1982
- Interaction of the antihypertensive drug felodipine with calmodulinNature, 1981
- Calcium antagonists: definition and mode of actionBasic Research in Cardiology, 1981
- Characterization of calmodulin effects on calcium transport in cardiac microsomes enriched in sarcoplasmic reticulumBiochemistry, 1980
- Calcium antagonistsAmerican Heart Journal, 1980
- Regulation and Kinetics of the Actin-Myosin-ATP InteractionAnnual Review of Biochemistry, 1980
- Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth MuscleAnnual Review of Pharmacology and Toxicology, 1977
- INHIBITION OF EXCITATION-CONTRACTION COUPLING IN THE VENTRICULAR MYOCARDIUM OF THE DOG BY SKF 24260Clinical and Experimental Pharmacology and Physiology, 1976